Sartorius Stedim Biotech (Sartorius Stedim Biotech) Other Current Liabilities : $447 Mil (As of Dec. 2023)

View and export this data going back to . Start your Free Trial

What is Sartorius Stedim Biotech Other Current Liabilities?

Sartorius Stedim Biotech's other current liabilities for the quarter that ended in Dec. 2023 was $447 Mil.

Sartorius Stedim Biotech's quarterly other current liabilities declined from Jun. 2023 ($275 Mil) to Sep. 2023 ($264 Mil) but then increased from Sep. 2023 ($264 Mil) to Dec. 2023 ($447 Mil).

Sartorius Stedim Biotech's annual other current liabilities declined from Dec. 2021 ($656 Mil) to Dec. 2022 ($583 Mil) and declined from Dec. 2022 ($583 Mil) to Dec. 2023 ($447 Mil).

Sartorius Stedim Biotech Other Current Liabilities Historical Data

The historical data trend for Sartorius Stedim Biotech's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sartorius Stedim Biotech Other Current Liabilities Chart

Sartorius Stedim Biotech Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Current Liabilities

Get a 7-Day Free Trial

Sartorius Stedim Biotech Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Other Current Liabilities	Get a 7-Day Free Trial															-	-	-	-	-

Sartorius Stedim Biotech Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

Sartorius Stedim Biotech Other Current Liabilities Related Terms

Thank you for viewing the detailed overview of Sartorius Stedim Biotech's Other Current Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Sartorius Stedim Biotech (Sartorius Stedim Biotech) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Sartorius Stedim Biotech SA (OTCPK:SDMHF) » Definitions » Other Current Liabilities

Comparable Companies

Traded in Other Exchanges

SRTOY:USA DIM:Mexico DIMp:UK 0RG8:UK DIM:France 56S1:Germany

Address

Otto-Brenner-Strasse 20, Goettingen, DEU, 37079

Website

https://www.sartorius.com

Sartorius Stedim Biotech, or SSB, is a leading provider of bioprocessing solutions. Its sells equipment and consumables for fermentation, filtration, fluid management, purification, and cell culture media for manufacturing biologic drugs, and has a focus on single-use technology, or SUT. It is a subsidiary of Sartorius AG, which has a 74% ownership and 85% voting control. The business is geographically diverse.